MAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway
Our findings highlight the critical role of the MAZ/UBE2C/MAPK signaling axis in the progression of breast cancer and identify potential novel therapeutic targets for its treatment.
Authors
- Jinhui Bai
- C M Xiong
- L Wang
- Jie Qin (ORCID: https://orcid.org/0000-0002-9733-3148)
- Mei Deng (ORCID: https://orcid.org/0000-0003-0480-5730)
- Huixian Wu
- Xueting Wu
Institutions
- Guilin Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1016/j.tranon.2025.102646
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00